Metraipolis › archive › dc_ebddae373f48

Post-marketing safety profile of meningococcal group B vaccines: a real-world disproportionality analysis of the VAERS database, 2015Q1-2025Q3 — Europe PMC PMID:41929253

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41929253
DOI
10.3389/fphar.2026.1745876
License (as archived)
solo-consultazione
Archived
2026-11-04T06:26:32.447Z
SHA-256 of the archived text
2deffd0b930f3725c611899a0e63ea2348e9fcc6f58a77e8c810ee18ab385d55
Stable URL of this page
https://metraipolis.com/documento/dc_ebddae373f48

How to cite

Post-marketing safety profile of meningococcal group B vaccines: a real-world disproportionality analysis of the VAERS database, 2015Q1-2025Q3 — Europe PMC PMID:41929253 — Europe PMC (en), https://europepmc.org/article/MED/41929253 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ebddae373f48 (Metraipolis archive dc_ebddae373f48, sha256 2deffd0b930f3725c611899a0e63ea2348e9fcc6f58a77e8c810ee18ab385d55)
BibTeX
@misc{dcebddae373f48,
  title = {Post-marketing safety profile of meningococcal group B vaccines: a real-world disproportionality analysis of the VAERS database, 2015Q1-2025Q3 — Europe PMC PMID:41929253},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41929253},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ebddae373f48; sha256 2deffd0b930f3725c611899a0e63ea2348e9fcc6f58a77e8c810ee18ab385d55},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41929253. Agents can read the archived copy with the MCP tool read_document.